Addition of low dose of metformin to the oral contraceptive has no great advantage in terms of cardiovascular risk markers in women with polycystic ovary syndrome regardless insulin resistance

✍ Scribed by C.S. Vieira; J.B.F. Fernandes; G.M. Soares; W.P. Martins; M.F. Silva-de-Sá; R.A. Ferriani

• Book ID: 116477424
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 60 KB
• Volume: 94
• Category: Article
• ISSN: 1556-5653
• DOI: 10.1016/j.fertnstert.2010.07.248